
Scientist – Upstream Vaccines and Advanced Biotechnologies Process R&D (Onsite)
Merck
Summary
Vaccines and Advanced Biotechnologies Process R&D is responsible for the development and clinical manufacturing of Drug Substance and Drug Product Intermediates for the vaccine and advanced therapy pipeline. We are seeking a motivated Scientist to join our upstream process development team, with a specialized focus on microbial strain engineering and fermentation.
Job description
Role Summary
Vaccines and Advanced Biotechnologies Process R&D is responsible for the development and clinical manufacturing of Drug Substance and Drug Product Intermediates for the vaccine and advanced therapy pipeline. We are seeking a motivated Scientist to join our upstream process development team, with a specialized focus on microbial strain engineering and fermentation.
Under the direction of the group leader, the individual will be responsible for upstream process development of vaccine candidates with a specialized focus on microbial strain engineering, microbial genetics, and fermentation. The successful candidate will design, construct, and evaluate genetically engineered microbial expression systems (bacterial and yeast/fungal), optimize codon/expression cassettes, and develop fermentation processes for vaccine production.
This position requires the employee to be willing to work with infectious agents and/or pathogens and may require occasional travel and off-hour/weekend work.
Responsibilities
- Independently design, construct, and genetically manipulate recombinant microbial strains (bacteria such as E. coli, and yeast/fungi such as Saccharomyces or Pichia) to optimize target antigen expression, quality, and yield.
- Apply molecular cloning strategies and design customized expression cassettes (promoters, signal peptides, selection markers) to control and optimize gene expression.
- Conduct laboratory bench work to execute, optimize, and troubleshoot microbial fermentation processes using shake flasks, automated high-throughput bioreactor systems such as ambr® 250, and bench/pilot-scale bioreactors.
- Perform host engineering utilizing bacterial and yeast genetics (e.g., Lambda Red, diploid construction, plasmid curing) to achieve desired strain phenotypes.
- Execute molecular biology unit operations including nucleic acid extraction (plasmid, genomic DNA, RNA), PCR assay suite development, and NGS library preparation.
- Apply quantitative data analysis and basic data science/modeling approaches (e.g., statistics, Design of Experiments (DoE)) to accelerate strain performance evaluation and fermentation optimization.
- Keep accurate, detailed laboratory records; maintain equipment inventories; and comply with all safety and training protocols for working with pathogens.
Education Minimum Requirement
Must have a BS or MS in a relevant field such as Molecular Biology, Genetics, Microbiology, Biochemistry, Biotechnology, Bioengineering, Chemical Engineering, Biomedical Engineering, or related disciplines.
Required Experience and Skills
- For BS: At least two (2) years of post-graduate experience in a bioprocess, biotechnology, or molecular biology-related position (vaccines and/or therapeutic proteins).
- For MS: At least one (1) year of post-graduate experience in a bioprocess, biotechnology, or molecular biology-related position (vaccines and/or therapeutic proteins) or a relevant academic research thesis.
- Hands-on proficiency with modern molecular cloning techniques (e.g., Restriction/Ligation, Gibson Assembly, Golden Gate cloning).
- Demonstrated experience using plasmid design and molecular biology software (e.g., Geneious, Snapgene) for virtual cloning, sequence validation, and annotation.
- Solid experience in nucleic acid extraction (plasmid, genomic DNA, RNA) and diverse PCR applications (primer design, colony PCR, real-time/quantitative PCR (qPCR), or digital PCR (dPCR)).
- Experience in strain design and engineering, including bacterial and/or yeast/fungal transformation and genetic manipulation (e.g., Lambda Red, CRISPR, Homologous Recombination).
- Experience executing, monitoring, and optimizing microbial fermentation utilizing bench-scale bioreactors, shake flasks, or high-throughput microbioreactor platforms.
- Excellent organization, interpersonal, verbal, and written communication skills, with a demonstrated ability to draft clear technical reports.
Preferred Experience and Skills
- Direct experience programming, operating, and analyzing data from ambr® 250 high-throughput systems to accelerate strain screening, media optimization, or Design of Experiments (DoE) execution.
- Prior experience with CRISPR-mediated gene editing and Homologous Recombination / Homology-Directed Repair (HDR) systems in microbes.
- Experience with NGS library preparation, genome sequencing, assembly, and annotation workflows.
- Experience with mammalian cell line development (e.g., Chinese Hamster Ovary (CHO) Cell Line Development (CLD) workflows) is considered a plus.
- Prior experience in codon optimization and expression cassette selection (e.g., promoter and signal peptide screening) to improve recombinant protein folding, secretion, or accumulation.
- Experience with data science and modeling tools (e.g., Design of Experiments (DoE), Python, R, or similar tools for bioprocess data visualization and analysis).
- Sound understanding of microbial process scale-up principles (e.g., oxygen transfer, power input, feeding strategies).
Requirements
- BS or MS in Molecular Biology, Genetics, Microbiology, Biochemistry, Biotechnology, Bioengineering, Chemical Engineering, Biomedical Engineering, or related field
- For BS: at least 2 years of post-graduate experience in bioprocess, biotechnology, or molecular biology-related position
- For MS: at least 1 year of post-graduate experience in bioprocess, biotechnology, or molecular biology-related position or relevant academic research thesis
- Hands-on proficiency with modern molecular cloning techniques (Restriction/Ligation, Gibson Assembly, Golden Gate cloning)
- Experience using plasmid design and molecular biology software (Geneious, Snapgene) for virtual cloning, sequence validation, and annotation
- Experience in nucleic acid extraction (plasmid, genomic DNA, RNA) and diverse PCR applications (primer design, colony PCR, qPCR, dPCR)
- Experience in strain design and engineering including bacterial and/or yeast/fungal transformation and genetic manipulation (Lambda Red, CRISPR, Homologous Recombination)
- Experience executing, monitoring, and optimizing microbial fermentation using bench-scale bioreactors, shake flasks, or high-throughput microbioreactor platforms
- Excellent organization, interpersonal, verbal, and written communication skills with ability to draft clear technical reports
- Willingness to work with infectious agents and/or pathogens
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Retirement Benefits
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.